Physician profile
Margaret E Kinney
NPI 1326471517
$13,135.07
in general payments reported to CMS, 2019-2025
35 companies · $3,359 in 2025
The $3,359 reported for 2025 was more than what 97% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $918 · 2022: $3,097 · 2023: $1,443 · 2024: $4,318 · 2025: $3,359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,560 · Travel and Lodging: $2,540 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,560.06 |
| Travel and Lodging | $2,539.71 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,707.11 | 2022-2025 | Cardiomems, Triclip |
| Boston Scientific Corporation | $1,498.65 | 2023-2024 | Watchman Flx, Watchman Access System |
| Medtronic, INC. | $1,419.81 | 2023-2025 | Symplicity G3, Corevalve Evolut R |
| Novartis Pharmaceuticals Corporation | $1,345.05 | 2021-2025 | |
| Janssen Research & Development, LLC | $1,163.34 | 2024 | |
| Amgen INC. | $699.81 | 2021-2025 | Repatha, Repatha |
| Actelion Pharmaceuticals US, INC. | $594.21 | 2021-2023 | Opsumit, Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $567.31 | 2022-2024 | Jardiance, Ofev |
| Pfizer INC. | $552.34 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $490.73 | 2022-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $391.25 | 2021-2025 | Lifevest |
| Heartflow, INC. | $354.33 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $329.38 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $289.48 | 2021-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $254.38 | 2021-2025 | Wainua, Farxiga |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $227.01 | 2021-2023 | Xarelto |
| Impulse Dynamics (USA) INC. | $210.21 | 2022-2023 | Optimizer |
| Scpharmaceuticals INC. | $184.83 | 2023-2025 | |
| Kiniksa Pharmaceuticals, LTD. | $126.92 | 2021-2023 | Arcalyst |
| Bridgebio Pharma, INC. | $111.60 | 2025 | Attruby |
| Abiomed | $95.89 | 2025 | |
| Esperion Therapeutics, INC. | $86.56 | 2021-2022 | |
| Edwards Lifesciences Corporation | $68.04 | 2024 | Sapien 3 Ultra Resilia |
| Daiichi Sankyo INC. | $67.82 | 2022-2023 | Injectafer |
| Alnylam Pharmaceuticals INC. | $47.51 | 2024-2025 | Onpattro |
| Kiniksa Pharmaceuticals International, Plc | $43.03 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $33.84 | 2023-2024 | Inpefa |
| Azurity Pharmaceuticals, INC. | $32.32 | 2024 | Edarbi |
| Atricure, INC. | $28.14 | 2024 | |
| Genzyme Corporation | $26.46 | 2024 | |
| Lantheus Medical Imaging, INC. | $24.09 | 2024 | |
| Sanofi-Aventis U.S. LLC | $19.83 | 2023 | |
| Amarin Pharma, INC. | $16.26 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.49 | 2022 | |
| Philips North America LLC | $13.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Kinney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.